Overall, these data indicate that triggering of TNFRS4 signaling on Tregs promotes antileukemic immunity and promotes elimination of CML LSCs by CD8+ CTLs. Here, CD8A is linked to chronic myelogenous leukemia, BCR-ABL1 positive.